Depo-subQ Provera 104
Generic name: Medroxyprogesterone (injection)
Brand names: Depo-subQ Provera
Dosage form: subcutaneous suspension (104 mg/0.65 mL)
Usage of Depo-subQ Provera 104
Depo-subQ Provera 104 (medroxyprogesterone) is a form of progesterone, a female hormone that prevents ovulation (the release of an egg from an ovary). Medroxyprogesterone also causes changes in your cervical mucus and uterine lining, making it harder for sperm to reach the uterus and harder for a fertilized egg to attach to the uterus.
Depo-subQ Provera 104 is used as contraception (birth control) to prevent pregnancy.
Depo-subQ Provera 104 is also used to reduce pain caused by endometriosis. Symptoms of endometriosis arise when cells normally inside your uterus grow outside the uterus. The cells respond to menstrual cycle hormones, and may cause painful periods, pelvic pain, and painful sex.
Depo-subQ provera 104 is given as a suBCutaneous injection (shot given under the skin) every 3 months.
Depo-subQ Provera 104 side effects
Get emergency medical help if you have signs of an allergic reaction to Depo-subQ provera 104: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Depo-subQ provera 104 side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Depo-subQ Provera 104
You may need to have a negative pregnancy test before you start Depo-subQ Provera 104.
You should not use Depo-subQ Provera 104 if you are pregnant, or if you have:
Depo-subQ Provera 104 can decrease the calcium stored in your bones, which may cause bone loss (osteoporosis) when the medicine is used over long periods of time. Bone loss may not be reversible.
You may be more likely to have a broken bone if your bones get weak from calcium loss, especially after menopause. You should not use Depo-subQ Provera 104 for longer than 2 years unless other birth control methods are not right for you. Ask your doctor.
To make sure Depo-subQ provera 104 is safe for you, tell your doctor if you have: ever had:
Tell your doctor right away if you become pregnant, or if you plan to become pregnant soon after you stop using Depo-subQ Provera 104.
It may not be safe to breastfeed while using Depo-subQ Provera 104. Ask your doctor about any risk.
How to use Depo-subQ Provera 104
Usual Adult Dose of Depo-subQ Provera 104 for Contraception:
Subcutaneous injection: -104 mg once every 3 months (12 to 14 weeks) into the anterior thigh or abdomen.
Usual Pediatric Dose of Depo-subQ Provera 104 for Contraception:
Postmenarchal children and adolescents: Subcutaneous injection: -104 mg once every 3 months (12 to 14 weeks) into the anterior thigh or abdomen.
Comments: First injection: -Ensure the patient is not pregnant at the time of the first Depo-subQ Provera 104 injection. -The first injection should be given only during the first 5 days of a normal menstrual period, within the first 5-days postpartum if not breast-feeding, and at the sixth postpartum week if breast-feeding. Switching from other methods of contraception: - The first Depo-subQ Provera 104 injection should be given within 7 days after the last day taking the last active contraceptive tablet, or after removing the patch or ring.
The risk/benefit of loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that occurs during pregnancy and/or lactation, should be assessed when using the injection long-term.
Usual Adult Dose of Depo-subQ Provera 104 for Endometriosis:
104 mg subcutaneously once every 3 months (12 to 14 weeks) Duration of therapy: No longer than two years.
Comments: -For sexually active women having regular menses, the first Depo-subQ Provera 104injection should only be given within the first 5 days of a normal menstrual period or at 6 weeks postpartum, if the patient is breast feeding. -If the period between injections is more than 14 weeks, pregnancy should be ruled out prior to administering. -The impact of long-term use of the Depo-subQ Provera 104 subcutaneous injection on bone mineral density (BMD) should be considered. -If symptoms return after discontinuation of treatment, BMD should be evaluated prior to retreatment.
Warnings
You should not use Depo-subQ Provera 104 if you have: undiagnosed vaginal bleeding, liver disease, breast cancer, if you are pregnant, or if you have ever had a stroke or blood clot.
Depo-subQ Provera 104 can decrease the calcium stored in your bones, which may cause bone loss (osteoporosis) when the medicine is used over long periods of time. Bone loss may not be reversible.
You may be more likely to have a broken bone if your bones get weak from calcium loss, especially after menopause. You should not use Depo-subQ Provera 104 for longer than 2 years unless other birth control methods are not right for you.
What other drugs will affect Depo-subQ Provera 104
Sometimes it is not safe to use certain medications at the same time. Some drugs can lower your blood levels of medroxyprogesterone and make it less effective in preventing pregnancy.
Tell your doctor about all your other medicines, especially:
This list is not complete and many other drugs may interact with medroxyprogesterone. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions